• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西沙必利治疗脊髓横断所致胃肠道及泌尿系统后遗症:病例报告

Treatment with cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report.

作者信息

Etienne M, Verlinden M, Brassinne A

机构信息

Hopital de Bavière, University of Liège, Department of Gastroenterology, Belgium.

出版信息

Paraplegia. 1988 Jun;26(3):162-4. doi: 10.1038/sc.1988.26.

DOI:10.1038/sc.1988.26
PMID:3419862
Abstract

We describe the case of a paraplegic patient who suffered traumatic spinal cord injury at the level of the twelfth thoracic vertebra. Within a short period of time following the injury, urinary (neuropathic bladder) and gastrointestinal (atomic colon) sequelae arose. Treatment with Cisapride (R 51 619, Janssen Pharmaceutica) was undertaken in an attempt to increase colonic motility and to reduce urinary retention. These goals were reached rapidly with a dose of 10 mg q.i.d.; the effect has been maintained for at least 18 months since starting the therapy.

摘要

我们描述了一名截瘫患者的病例,该患者在第十二胸椎水平遭受了创伤性脊髓损伤。在损伤后的短时间内,出现了泌尿系统(神经源性膀胱)和胃肠道(无张力结肠)后遗症。使用西沙必利(R 51 619,杨森制药公司)进行治疗,试图增加结肠蠕动并减少尿潴留。每日四次服用10毫克的剂量迅速实现了这些目标;自开始治疗以来,这种效果已维持了至少18个月。

相似文献

1
Treatment with cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report.西沙必利治疗脊髓横断所致胃肠道及泌尿系统后遗症:病例报告
Paraplegia. 1988 Jun;26(3):162-4. doi: 10.1038/sc.1988.26.
2
Effects of cisapride on constipation due to a neurological lesion.西沙必利对神经病变所致便秘的影响。
Paraplegia. 1988 Jun;26(3):159-61. doi: 10.1038/sc.1988.25.
3
The effects of 4 weeks treatment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study.西沙必利治疗4周对脊髓损伤患者膀胱测压参数的影响。一项双盲、安慰剂对照研究。
Paraplegia. 1995 Nov;33(11):625-7. doi: 10.1038/sc.1995.132.
4
[A clinical-pharmacological case (1). Action of cisapride (Prepulsid) on bladder function].[临床药理学病例(1)。西沙必利(普瑞博思)对膀胱功能的作用]
Praxis (Bern 1994). 1996 Jan 16;85(3):62-4.
5
The effect of cisapride on segmental colonic transit time in patients with spinal cord injury.西沙必利对脊髓损伤患者节段性结肠转运时间的影响。
Am J Gastroenterol. 1995 Feb;90(2):285-9.
6
The action of cisapride on the chronic constipation of paraplegia.西沙必利对截瘫所致慢性便秘的作用。
Paraplegia. 1988 Jun;26(3):151-8. doi: 10.1038/sc.1988.24.
7
Cisapride stimulates small intestinal motility and relieves constipation in myelopathy due to cervical spinal stenosis: case report.西沙必利可刺激小肠蠕动并缓解颈椎管狭窄所致脊髓病中的便秘:病例报告。
Paraplegia. 1990 May;28(4):261-4. doi: 10.1038/sc.1990.33.
8
Gastrointestinal transit after spinal cord injury: effect of cisapride.脊髓损伤后的胃肠转运:西沙必利的作用
Am J Gastroenterol. 1992 Nov;87(11):1614-7.
9
[[The effect of cisapride on the neurogenic bladder].[西沙必利对神经源性膀胱的影响]
Acta Belg Med Phys. 1989 Jul-Sep;12(3):81-8.
10
Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients.西沙必利对脊髓损伤患者肛门直肠及膀胱尿道功能的影响。
Paraplegia. 1993 Feb;31(2):125-7. doi: 10.1038/sc.1993.22.

引用本文的文献

1
Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle.匹莫色罗(SB 207266),一种选择性5-羟色胺4受体拮抗剂,可降低5-羟色胺对人逼尿肌神经介导的收缩反应的增强作用。
World J Urol. 2005 Jun;23(2):147-51. doi: 10.1007/s00345-005-0499-z. Epub 2005 May 18.
2
Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.人离体逼尿肌中的神经5-羟色胺4受体:吲哚、苯并咪唑酮及取代苯甲酰胺激动剂和拮抗剂的作用
Br J Pharmacol. 1996 Aug;118(8):1965-70. doi: 10.1111/j.1476-5381.1996.tb15631.x.
3
A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
西沙必利治疗胃肠道疾病的风险效益评估。
Drug Saf. 1995 Jun;12(6):384-92. doi: 10.2165/00002018-199512060-00004.
4
Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.西沙必利。作为胃肠动力障碍促动力剂的药理学及治疗效果的最新综述。
Drugs. 1994 Jan;47(1):116-52. doi: 10.2165/00003495-199447010-00008.